Clinical Efficacy of Patients With Secondary Bacteremia Treated With Omadacycline: Results From Phase 3 Acute Bacterial Skin and Skin Structure Infections and Community-Acquired Bacterial Pneumonia Studies.

Sakoulas, George; Eckburg, Paul B; Amodio-Groton, Maria; Manley, Amy; Tzanis, Evan; Das, Anita F; Noble, Robert; McGovern, Paul C

Sakoulas, George; Eckburg, Paul B; Amodio-Groton, Maria; Manley, Amy; Tzanis, Evan; Das, Anita F; Noble, Robert; McGovern, Paul C.

Afiliação

Sakoulas G; University of California, San Diego, California, USA.
Eckburg PB; Paratek Pharmaceuticals Inc., King of Prussia, Philadelphia, USA.
Amodio-Groton M; Paratek Pharmaceuticals Inc., King of Prussia, Philadelphia, USA.
Manley A; Paratek Pharmaceuticals Inc., King of Prussia, Philadelphia, USA.
Tzanis E; Paratek Pharmaceuticals Inc., King of Prussia, Philadelphia, USA.
Das AF; AD Stats Consulting, Guerneville, California, USA.
Noble R; Paratek Pharmaceuticals Inc., King of Prussia, Philadelphia, USA.
McGovern PC; Paratek Pharmaceuticals Inc., King of Prussia, Philadelphia, USA.

Open Forum Infect Dis ; 8(6): ofab136, 2021 Jun.

Article em En | MEDLINE | ID: mdl-34160473

Palavras-chave

acute bacterial skin and skin structure infections; community-acquired pneumonia; efficacy; omadacycline; secondary bacteremia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Open Forum Infect Dis Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google